Validation of self‐reported medication use for hypertension, diabetes, and dyslipidemia among employees of large‐sized companies in Japan
Validation of self‐reported medication use for hypertension, diabetes, and dyslipidemia among employees of large‐sized companies in Japan
复制标题
日本大型企业员工自我报告的高血压、糖尿病和血脂异常药物使用情况的验证
DOI：
10.1002/1348-9585.12138
复制
发表时间：
2020
影响因子：
3
通讯作者：
Fujino Yoshihisa
中科院分区：
文献类型：
--
作者：
Fukai Kota;Nagata Tomohisa;Mori Koji;Ohtani Makoto;Fujimoto Kenji;Nagata Masako;Fujino Yoshihisa
本研究的目的是评估自我报告的高血压，糖尿病和血脂异常的药物使用的有效性，通过比较与健康保险索赔之间的员工的大型companies in Japanes.MethodsParticipants的13个大型公司在日本的61 676名参与者。药物使用的自我报告是通过2016财年年度健康检查中进行的网络或纸质问卷获得的。从2016年4月1日至2017年3月31日，从企业健康保险协会获得了药物的健康保险索赔。对不同参考期（1个月、2个月、3个月和1年）的一致率、敏感性、特异性、阳性和阴性预测值（PPV和NPV）以及自我报告的kappa统计进行了检查。按性别、年龄、体重指数、吸烟、饮酒、血压、血红蛋白A1c和低密度脂蛋白胆固醇分层进行亚组分析。结果高血压的一致性、敏感性、特异性、PPV和NPV分别为0.98、0.90、0.98、0.87和0.99，3个月的自我报告和索赔数据之间，糖尿病和血脂异常分别为0.98、0.86、0.99、0.83和0.99。Kappa统计量在3个月的高血压、糖尿病和血脂异常索赔数据参考期内最高。没有重大的一致性观察subgroup.ConclusionThis验证自我报告的药物使用高血压，糖尿病和血脂异常显示几乎完美的可靠性，在日本的大型公司的员工。
ObjectiveThe aim of this study was to evaluate the validity of self-reported medication use for hypertension, diabetes, and dyslipidemia by comparison with health insurance claims among employees of large-sized companies in Japan.MethodsParticipants were 61 676 participants of 13 large-sized companies in Japan. Self-reports on medication use were obtained through web- or paper-based questionnaires conducted at the annual health checkup in fiscal year 2016. Health insurance claims for medication were obtained from corporate health insurance associations from April 1, 2016, to March 31, 2017. Agreement rate, sensitivity, specificity, positive and negative predictive values (PPV and NPV), and kappa statistics of self-reporting were examined for different reference periods (1-, 2-, and 3- months, and 1-year). Subgroup analysis was conducted stratified by sex, age, body mass index, smoking, alcohol drinking, blood pressure, hemoglobin A1c, and low-density lipoprotein cholesterol.ResultsAgreement, sensitivity, specificity, PPV, and NPV were 0.98, 0.90, 0.98, 0.87, and 0.99 for hypertension, 0.99, 0.89, 1.00, 0.89, and 1.00 for diabetes, and 0.98, 0.86, 0.99, 0.83, and 0.99 for dyslipidemia, respectively, between self-reports and claims data for 3 months. Kappa statistics were highest with the 3-month reference period of claims data for hypertension, diabetes, and dyslipidemia. No major concordance was observed between the subgroups.ConclusionThis validation of self-reported medication use for hypertension, diabetes, and dyslipidemia showed almost perfect reliability among employees of large-sized companies in Japan.
登录
查看更多内容
DOI：
10.11236/jph.64.10_619
发表时间：
2017-01-01
期刊：
[Nihon koshu eisei zasshi] Japanese journal of public health
影响因子：
--
作者：
Kubo, Shinichiro;Noda, Tatsuya;Imamura, Tomoaki
通讯作者：
Imamura, Tomoaki
影响因子：
7.2
作者：
Richardson, Kathryn;Kenny, Rose Anne;Bennett, Kathleen
通讯作者：
Bennett, Kathleen
影响因子：
5.9
作者：
G. Fowler
通讯作者：
G. Fowler
影响因子：
3
作者：
Tisnado, DM;Adams, JL;Kahn, KL
通讯作者：
Kahn, KL
影响因子：
2.9
作者：
Fujita M;Sato Y;Nagashima K;Takahashi S;Hata A
通讯作者：
Hata A